The Latest Cardiac and Vascular News
TOKYO, JAPAN – April 24, 2018 – Terumo Aortic announced the European limited market release of the RelayPro Thoracic Stent-Graft System at the 2018 Charing Cross conference. RelayPro is a low profile, next generation device designed to expand the treatment […]
New company brings together two leaders in the aortic implant market New identity underlines global growth ambitions further to $43m factory investment Merger unites two world-class innovators focused on expanding aortic treatment options Vascutek and Bolton Medical have combined into […]
DUBLIN–(BUSINESS WIRE)–The “Transradial Access Market by Product (Catheters, Guidewires, Sheath and Sheath Introducers), Application (Administration of Medicine and Administration of fluids), End User (Hospitals, Clinics & Ambulatory Centres) – Global Forecast 2022” report has been added to ResearchAndMarkets.com’s offering. The Global Transradial Access Devices […]
ALISO VIEJO, Calif., Sept. 26, 2017 /PRNewswire/ — MicroVention, a wholly owned subsidiary of Terumo Corporation and a global neurovascular company, today announced that the Grand Opening of its New Innovation Center was held on Monday, September 25. The opening of the new facility, […]
TOKYO, JAPAN – September 19, 2017 – Terumo Corporation (TSE: 4543) announced today that it has launched QuiremSpheres® microspheres on September 18 in Europe. QuiremSpheres® are available in Europe with plans for expansion its sales area outside of Europe in […]
ANN ARBOR, Mich., April 6, 2017 /PRNewswire/ — Terumo Cardiovascular (CV) Group today announced that Robert (Rob) DeRyke has been appointed President and CEO of Terumo CV Group, effective April 1, 2017, following the retirement of long-time President and CEO Mark […]
